Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cogent Biosciences (COGT) Return on Equity (2018 - 2020)

Historic Return on Equity for Cogent Biosciences (COGT) over the last 4 years, with Q3 2021 value amounting to 0.06%.

  • Cogent Biosciences' Return on Equity fell 466800.0% to 0.06% in Q3 2021 from the same period last year, while for Sep 2021 it was 0.06%, marking a year-over-year decrease of 466800.0%. This contributed to the annual value of 0.62% for FY2020, which is 800.0% up from last year.
  • Per Cogent Biosciences' latest filing, its Return on Equity stood at 0.06% for Q3 2021, which was down 466800.0% from 0.31% recorded in Q2 2021.
  • Over the past 5 years, Cogent Biosciences' Return on Equity peaked at 46.62% during Q3 2020, and registered a low of 3.89% during Q2 2018.
  • Its 4-year average for Return on Equity is 2.32%, with a median of 0.72% in 2019.
  • As far as peak fluctuations go, Cogent Biosciences' Return on Equity soared by 478700bps in 2020, and later crashed by -466800bps in 2021.
  • Cogent Biosciences' Return on Equity (Quarter) stood at 0.55% in 2018, then crashed by -94bps to 1.06% in 2019, then increased by 27bps to 0.77% in 2020, then soared by 93bps to 0.06% in 2021.
  • Its last three reported values are 0.06% in Q3 2021, 0.31% for Q2 2021, and 0.33% during Q1 2021.